Background/Aims The incidence of perianal lesions (PL) in children with Crohn’s disease (CD) is higher in East Asia than in Western countries. Early intervention for PL is essential to prevent sphincter dysfunction and ostomy placement. In this study, we aimed to investigate the clinical features, treatment, and consequences of pediatric CD with PL.
Methods We retrospectively reviewed a cohort of children diagnosed with CD from 2010 to 2020 at a Japanese children’s hospital. Demographics, treatments, and outcomes were evaluated and compared among subgroups.
Results Among 112 pediatric patients with CD, 36 (32.1%) had experienced PL during the observational period. The median ages at diagnosis and follow-up periods were 131 and 70 months, respectively. Six (85.7%) patients in the very early-onset (VEO) group (CD diagnosed before 6 years old) and 24 (82.8%) in the older age group had PL upon diagnosis of CD (P= 0.851). Biologics were given to 94.4% of patients: infliximab (67.7%), adalimumab (58.8%), ustekinumab (44.1%), risankizumab (11.8%), and vedolizumab (5.9%). Biologics were introduced within 1 year in 89.5% and 40.0% of patients diagnosed in 2016–2020 and 2010–2016, respectively (P= 0.002). Seton was frequently used in the older age group (87.5 vs. 42.9%, P= 0.190). Ostomy was frequently required in the VEO group (42.9% vs. 0.0%, P= 0.006).
Conclusions Patients with VEO-CD and PL had a notably high risk of ostomy placement. The earlier introduction of biologics and surgical interventions reduced corticosteroids use and ostomy placement in pediatric CD patients with PL.
Citations
Citations to this article as recorded by
Asian–Pacific perspectives on the management of very early-onset inflammatory bowel disease Ichiro Takeuchi, Katsuhiro Arai, Pornthep Tanpowpong, Ming-Wei Lai, Andrew S Day, Way Seah Lee, James Guoxian Huang, Karen Sophia Calixto-Mercado, Rosanna Ming Sum Wong, Muhammad Arshad Alvi, Zubin Grover, Jung Ok Shim, Ujjal Poddar Intestinal Research.2025; 23(4): 405. CrossRef
Background/Aims There are few published registry studies from Asia on pediatric inflammatory bowel disease (IBD). Registry network data enable comparisons among ethnic groups. This study examined the characteristics of IBD in Japanese children and compared them with those in European children.
Methods This was a cross-sectional multicenter registry study of newly diagnosed Japanese pediatric IBD patients. The Paris classification was used to categorize IBD features, and results were compared with published EUROKIDS data.
Results A total of 265 pediatric IBD patients were initially registered, with 22 later excluded for having incomplete demographic data. For the analysis, 91 Crohn’s disease (CD), 146 ulcerative colitis (UC), and 6 IBD-unclassified cases were eligible. For age at diagnosis, 20.9% of CD, 21.9% of UC, and 83.3% of IBD-unclassified cases were diagnosed before age 10 years. For CD location, 18.7%, 13.2%, 64.8%, 47.3%, and 20.9% were classified as involving L1 (ileocecum), L2 (colon), L3 (ileocolon), L4a (esophagus/stomach/duodenum), and L4b (jejunum/proximal ileum), respectively. For UC extent, 76% were classified as E4 (pancolitis). For CD behavior, B1 (non-stricturing/non-penetrating), B2 (stricturing), B3 (penetrating), and B2B3 were seen in 83.5%, 11.0%, 3.3%, and 2.2%, respectively. A comparison between Japanese and European children showed less L2 involvement (13.2% vs. 27.3%, P< 0.01) but more L4a (47.3% vs. 29.6%, P< 0.01) and L3 (64.8% vs. 52.7%, P< 0.05) involvement in Japanese CD children. Pediatric perianal CD was more prevalent in Japanese children (34.1% vs. 9.7%, P< 0.01).
Conclusions Upper gastrointestinal and perianal CD lesions are more common in Japanese children than in European children.
Citations
Citations to this article as recorded by
Long‐term clinical and endoscopic outcomes of ustekinumab in pediatric Crohn's disease with anti‐tumor necrosis factor failure Yoko Yamamoto, Ichiro Takeuchi, Hirotaka Shimizu, Hiroki Fujikawa, Masanori Toda, Eri Miyata, Hiroaki To, Satoru Nagata, Katsuhiro Arai Journal of Gastroenterology and Hepatology.2025; 40(1): 123. CrossRef
Outcome of pediatric inflammatory bowel disease in Asian children: a multinational 1-year follow-up study Pornthep Tanpowpong, Suporn Treepongkaruna, James Guoxian Huang, Kee Seang Chew, Karen Sophia Calixto Mercado, Almida Reodica, Shaman Rajindrajith, Wathsala Hathagoda, Yoko Kin Yoke Wong, Way Seah Lee, Marion Margaret Aw Clinical and Experimental Pediatrics.2025; 68(3): 247. CrossRef
Phenotypic Differences and Clinical Outcomes of South Asian Children With IBD: A Singapore–Malaysia Study From the Asian PIBD Registry Network James Guoxian Huang, Kee Seang Chew, Veena Logarajah, Way Seah Lee, Marion Margaret Aw Journal of Gastroenterology and Hepatology.2025; 40(8): 1933. CrossRef
Expert consensus on diagnostic guidelines for pediatric inflammatory bowel disease in Japan Takahiro Kudo, Katsuhiro Arai, Itaru Iwama, Shin-ichiro Hagiwara, Takashi Ishige, Koji Yokoyama, Fumihiko Kakuta, Keisuke Jimbo, Hiroki Kondou, Yugo Takaki, Shingo Kurasawa, Hiroki Fujikawa, Yuhki Koike, Fumihito Hirai, Shinya Ashizuka, Kenji Watanabe, To Journal of Gastroenterology.2025; 60(9): 1118. CrossRef
Two Decades of Pediatric Inflammatory Bowel Disease in North-Western Romania: Phenotypic Characteristics and Diagnostic Trends Georgia Valentina Tartamus (Tita), Daniela Elena Serban, Marcel Vasile Tantau Journal of Clinical Medicine.2025; 14(13): 4597. CrossRef
Growth impairment in Japanese children with inflammatory bowel disease: A multicenter prospective cohort study Hirotaka Shimizu, Ryusuke Nambu, Nao Tachibana, Reiko Kunisaki, Takahiro Kudo, Sawako Kato, Tatsuki Mizuochi, Hideki Kumagai, Mikihiro Inoue, Naomi Iwata, Takeshi Saito, Takashi Ishige, Toshifumi Yodoshi, Atsuko Noguchi, Shigeo Nishimata, Takahiro Mochizu Journal of Pediatric Gastroenterology and Nutrition.2025; 81(5): 1216. CrossRef
Pharmacist-Led Shared Decision-Making in a Pediatric Patient with Crohn’s Disease and Growth Failure: A Case Report Momoko Konaka-Yamamoto, Ikkou Hirata, Maho Hamaguchi, Yuki Ohta, Ryohkan Funakoshi YAKUGAKU ZASSHI.2025; 145(10): 857. CrossRef
Asian–Pacific perspectives on the management of very early-onset inflammatory bowel disease Ichiro Takeuchi, Katsuhiro Arai, Pornthep Tanpowpong, Ming-Wei Lai, Andrew S Day, Way Seah Lee, James Guoxian Huang, Karen Sophia Calixto-Mercado, Rosanna Ming Sum Wong, Muhammad Arshad Alvi, Zubin Grover, Jung Ok Shim, Ujjal Poddar Intestinal Research.2025; 23(4): 405. CrossRef
Inflammatory Bowel Disease in Jordanian Children: A Tertiary Center Experience Hala Almomani, Ayah Alsmadi, Nicole Issi, Maria AlShurman, Eyad Altamimi Pediatric Gastroenterology, Hepatology & Nutrition.2025; 28(6): 393. CrossRef
Utility of Small Bowel Capsule Endoscopy and Leucine-Rich Alpha-2-Glycoprotein in Pediatric Crohn’s Disease Management Satoshi Ukai, Shun Watanabe, Ayako Furuya, Tomomitsu Sado, Shingo Kurasawa, Atsuhiro Hirayama, Sawako Kato, Yoshiko Nakayama Cureus.2025;[Epub] CrossRef
Prognosis of pediatric ulcerative colitis after infliximab failure: A multicenter registry‐based cohort study Ryusuke Nambu, Takahiro Kudo, Nao Tachibana, Hirotaka Shimizu, Tatsuki Mizuochi, Sawako Kato, Mikihiro Inoue, Hideki Kumagai, Takashi Ishige, Reiko Kunisaki, Atsuko Noguchi, Toshifumi Yodoshi, Shin‐Ichiro Hagiwara, Shigeo Nishimata, Fumihiko Kakuta, Takes Journal of Gastroenterology and Hepatology.2024; 39(2): 312. CrossRef
Prevalence of Inflammatory Bowel Disease Unclassified, as Estimated Using the Revised Porto Criteria, among Korean Pediatric Patients with Inflammatory Bowel Disease Sung Hee Lee, Minsoo Shin, Seo Hee Kim, Seong Pyo Kim, Hyung-Jin Yoon, Yangsoon Park, Jaemoon Koh, Seak Hee Oh, Jae Sung Ko, Jin Soo Moon, Kyung Mo Kim Pediatric Gastroenterology, Hepatology & Nutrition.2024; 27(4): 206. CrossRef
Clinical Efficacy and Future Application of Indigo Naturalis in the Treatment of Ulcerative colitis Dianzhen Wu, Qi Huang, Yingbi Xu, Ruiyi Cao, Ming Yang, Jin Xie, Dingkun Zhang Journal of Ethnopharmacology.2024; : 118782. CrossRef
Validation of the simplified PIBD‐classes criteria: A single‐center retrospective study Yoshikazu Miura, Shin‐ichiro Hagiwara, Keinosuke Hizuka, Ryutaro Saura, Ayaha Hata, Takatoshi Maeyama, Yuri Etani Pediatrics International.2024;[Epub] CrossRef
Comparison of Clinical Outcomes in Pediatric Patients with Ileocolonic Crohn Disease Treated with Infliximab Versus Adalimumab Eliana Fanous, Tal Marshanski, Noa Tal, Manar Matar, Yael Weintraub, Raanan Shamir, Dror S. Shouval Journal of Pediatric Gastroenterology and Nutrition.2023; 77(3): 358. CrossRef
Caracterización clínica y terapéutica de una cohorte multicéntrica de pacientes con enfermedad inflamatoria intestinal en Colombia Viviana Parra-Izquierdo, Cristian Flórez Sarmiento, Juan Sebastián Frías-Ordoñez, Melquicedec Vargas, Joshua Kock, Natalia Lozano Escobar, Juan Ricardo Márquez Gastroenterología y Hepatología.2023; 46(8): 585. CrossRef
Potential of Gut Microbe-Derived Extracellular Vesicles to Differentiate Inflammatory Bowel Disease Patients from Healthy Controls Min Heo, Young Soo Park, Hyuk Yoon, Nam-Eun Kim, Kangjin Kim, Cheol Min Shin, Nayoung Kim, Dong Ho Lee Gut and Liver.2023; 17(1): 108. CrossRef
Medical management of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group Way Seah Lee, Katsuhiro Arai, George Alex, Suporn Treepongkaruna, Kyung Mo Kim, Chee Liang Choong, Karen S. C. Mercado, Andy Darma, Anshu Srivastava, Marion M. Aw Journal of Gastroenterology and Hepatology.2023; 38(4): 523. CrossRef
Clinical outcome of ulcerative colitis with severe onset in children: a multicenter prospective cohort study Ryusuke Nambu, Katsuhiro Arai, Takahiro Kudo, Takatsugu Murakoshi, Reiko Kunisaki, Tatsuki Mizuochi, Sawako Kato, Hideki Kumagai, Mikihiro Inoue, Takashi Ishige, Takeshi Saito, Atsuko Noguchi, Toshifumi Yodoshi, Shin-Ichiro Hagiwara, Naomi Iwata, Shigeo N Journal of Gastroenterology.2023; 58(5): 472. CrossRef
Mucosal immune systems of pediatric inflammatory bowel disease: A review Takahiro Kudo, Toshiaki Shimizu Pediatrics International.2023;[Epub] CrossRef
Clinical and therapeutic characterisation of a multicentre cohort of patients with inflammatory bowel disease in Colombia Viviana Parra-Izquierdo, Cristian Flórez Sarmiento, Juan Sebastián Frías-Ordoñez, Melquicedec Vargas, Joshua Kock, Natalia Lozano Escobar, Juan Ricardo Márquez Gastroenterología y Hepatología (English Edition).2023; 46(8): 585. CrossRef
Clinical characteristics and nursing diagnoses of pediatric patients hospitalized with inflammatory bowel disease: a single-center retrospective study in South Korea Sung-Yoon Jo, Kyung-Sook Bang Child Health Nursing Research.2023; 29(3): 218. CrossRef
Clinical Features and Long-Term Outcomes of Paediatric-Onset Inflammatory Bowel Disease in a Population-Based Cohort in the Songpa-Kangdong District of Seoul, Korea Sang Hyoung Park, Jong Pil Im, Hyunju Park, Seung Kyu Jeong, Ji Hyun Lee, Kyoung Hoon Rhee, Young-Ho Kim, Sung Noh Hong, Kyung Ho Kim, Seung In Seo, Jae Myung Cha, Sun Yong Park, Joo Sung Kim, Hyuk Yoon, Sung Hoon Kim, Jisun Jang, Jeong Hwan Kim, Seong O Journal of Crohn's and Colitis.2022; 16(2): 207. CrossRef
Long-term Disease Course of Crohn’s Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors Choong Wui Cho, Myung-Won You, Chi Hyuk Oh, Chang Kyun Lee, Sung Kyoung Moon Gut and Liver.2022; 16(2): 157. CrossRef
Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study Katsuyoshi Matsuoka, Katsumasa Nagano, Shinya Nagasaki, Yoko Murata, Tadakazu Hisamatsu BMJ Open.2022; 12(5): e060081. CrossRef
Personalized medicine in inflammatory bowel disease: Perspectives on Asia Su Hyun Park, Sang Hyoung Park Journal of Gastroenterology and Hepatology.2022; 37(8): 1434. CrossRef
Phenotypic Pattern of Early Versus Later‐Onset Pediatric Inflammatory Bowel Disease in a Eurasian Country Bilge S. Akkelle, Deniz Ertem, Burcu Volkan, Engin Tutar Journal of Pediatric Gastroenterology and Nutrition.2022;[Epub] CrossRef
Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study Masaaki Usami, Ichiro Takeuchi, Reiko Kyodo, Yuri Hirano, Kosuke Kashiwagi, Hiroki Fujikawa, Hirotaka Shimizu, Toshinao Kawai, Katsuhiro Arai Intestinal Research.2022; 20(4): 475. CrossRef
SYSTEMATIC REVIEW AND META - ANALYSIS OF THE FREQUENCY AND RE-CLASSIFICATION TRENDS OF PEDIATRIC INFLAMMATORY BOWEL DISEASE - UNCLASSIFIED Rishi BOLIA, Akhil Dhanesh GOEL Arquivos de Gastroenterologia.2022; 59(4): 531. CrossRef
Comparison between Pediatric Crohn’s Disease and Ulcerative Colitis at Diagnosis in Korea: Results from a Multicenter, Registry-Based, Inception Cohort Study Sowon Park, Ben Kang, Seung Kim, Sujin Choi, Hyo Rim Suh, Eun Sil Kim, Ji Hyung Park, Mi Jin Kim, Yon Ho Choe, Yeoun Joo Lee, Jae Hong Park, Eell Ryoo, Hong Koh, Byung-Ho Choe Gut and Liver.2022; 16(6): 921. CrossRef
Epidemiology and diagnosis of inflammatory bowel diseases Kang-Moon Lee Journal of the Korean Medical Association.2021; 64(9): 579. CrossRef
Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease Rupa Banerjee, Partha Pal, Zaheer Nabi, Upender Shava, Girish Ganesh, D. Nageshwar Reddy Intestinal Research.2021; 19(4): 398. CrossRef
Incidentally Detected Asymptomatic Perianal Abscess in an Adolescent during Crohn's Disease Diagnosis: Is Routine Pelvic Imaging Required in Korean Pediatric Patients at Diagnosis? Soo Hyun Um, Sang Woo Lee, Ki Hwan Song, So Mi Lee, Byung-Ho Choe, Yoo Min Lee, Ben Kang Pediatric Gastroenterology, Hepatology & Nutrition.2021; 24(6): 564. CrossRef